BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36040459)

  • 1. Interactions between FGF23 and vitamin D.
    Razzaque MS
    Endocr Connect; 2022 Oct; 11(10):. PubMed ID: 36040459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D and type II sodium-dependent phosphate cotransporters.
    Kido S; Kaneko I; Tatsumi S; Segawa H; Miyamoto K
    Contrib Nephrol; 2013; 180():86-97. PubMed ID: 23652552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of 25-hydroxyvitamin D-1-hydroxylase and 24-hydroxylase in keratinocytes by PTH and FGF23.
    Wu W; Fan H; Jiang Y; Liao L; Li L; Zhao J; Zhang H; Shrestha C; Xie Z
    Exp Dermatol; 2018 Nov; 27(11):1201-1209. PubMed ID: 30066343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF23, klotho and vitamin D interactions: What have we learned from in vivo mouse genetics studies?
    Razzaque MS
    Adv Exp Med Biol; 2012; 728():84-91. PubMed ID: 22396163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic mechanisms controlling renal vitamin D metabolism.
    Meyer MB; Pike JW
    J Steroid Biochem Mol Biol; 2023 Apr; 228():106252. PubMed ID: 36657729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro regulation of fibroblast growth factor 23 by 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D synthesized by osteocyte-like MC3T3-E1 cells.
    Ratsma DMA; Muller M; Koedam M; Zillikens MC; van der Eerden BCJ
    Eur J Endocrinol; 2023 Oct; 189(4):448-459. PubMed ID: 37796032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic homeostasis of vitamin D metabolism in the kidney through reciprocal modulation of Cyp27b1 and Cyp24a1 expression.
    Meyer MB; Pike JW
    J Steroid Biochem Mol Biol; 2020 Feb; 196():105500. PubMed ID: 31629064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphate Homeostasis, Inflammation and the Regulation of FGF-23.
    Lang F; Leibrock C; Pandyra AA; Stournaras C; Wagner CA; Föller M
    Kidney Blood Press Res; 2018; 43(6):1742-1748. PubMed ID: 30504710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of Vitamin D with Peptide Hormones with Emphasis on Parathyroid Hormone, FGF23, and the Renin-Angiotensin-Aldosterone System.
    Latic N; Erben RG
    Nutrients; 2022 Dec; 14(23):. PubMed ID: 36501215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of klotho-FGF23 fusion polypeptides: WO2009095372.
    Razzaque MS
    Expert Opin Ther Pat; 2010 Jul; 20(7):981-5. PubMed ID: 20459364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)2D3.
    Kägi L; Bettoni C; Pastor-Arroyo EM; Schnitzbauer U; Hernando N; Wagner CA
    PLoS One; 2018; 13(5):e0195427. PubMed ID: 29771914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FGF23 and Vitamin D Metabolism.
    Latic N; Erben RG
    JBMR Plus; 2021 Dec; 5(12):e10558. PubMed ID: 34950827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted genomic deletions identify diverse enhancer functions and generate a kidney-specific, endocrine-deficient
    Meyer MB; Benkusky NA; Kaufmann M; Lee SM; Redfield RR; Jones G; Pike JW
    J Biol Chem; 2019 Jun; 294(24):9518-9535. PubMed ID: 31053643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease.
    Quarles LD
    Exp Cell Res; 2012 May; 318(9):1040-8. PubMed ID: 22421513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic models show that parathyroid hormone and 1,25-dihydroxyvitamin D3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development.
    Xue Y; Karaplis AC; Hendy GN; Goltzman D; Miao D
    Hum Mol Genet; 2005 Jun; 14(11):1515-28. PubMed ID: 15843402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoids dexamethasone and prednisolone suppress fibroblast growth factor 23 (FGF23).
    Feger M; Ewendt F; Strotmann J; Schäffler H; Kempe-Teufel D; Glosse P; Stangl GI; Föller M
    J Mol Med (Berl); 2021 May; 99(5):699-711. PubMed ID: 33517471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of serum 1,25(OH)2 vitamin D3 levels by fibroblast growth factor 23 is mediated by FGF receptors 3 and 4.
    Gattineni J; Twombley K; Goetz R; Mohammadi M; Baum M
    Am J Physiol Renal Physiol; 2011 Aug; 301(2):F371-7. PubMed ID: 21561999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low serum 1,25(OH)2D3 in end-stage renal disease: is reduced 1α-hydroxylase the only problem?
    Huish SA; Jenkinson C; Dunn JA; Meredith DJ; Bland R; Hewison M
    Endocr Connect; 2021 Oct; 10(10):1291-1298. PubMed ID: 34519274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased conversion of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 following cholecalciferol therapy in patients with CKD.
    Stubbs JR; Zhang S; Friedman PA; Nolin TD
    Clin J Am Soc Nephrol; 2014 Nov; 9(11):1965-73. PubMed ID: 25183657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.